In recent years, high throughput discovery of human recombinant monoclonal antibodies (mAbs) has been applied to greatly advance our understanding of the specificity, and functional activity of antibodies against HIV. Thousands of antibodies have been generated and screened in functional neutralization assays, and antibodies associated with cross-strain neutralization and passive protection in primates, have been identified. To facilitate this type of discovery, a high throughput-screening tool is needed to accurately classify mAbs, and their antigen targets. In this study, we analyzed and evaluated a prototype microarray chip comprised of the HIV-1 recombinant proteins gp140, gp120, gp41, and several membrane proximal external region pepti...
Identification of broadly cross-reactive HIV-1-neutralizing antibodies (bnAbs) may assist vaccine im...
The monitoring and assessment of a broadly neutralizing antibody (bnAb) based HIV-1 vaccine require ...
Several new human monoclonal antibodies (mAbs) with a neutralizing potential across different subtyp...
In recent years, high throughput discovery of human recombinant monoclonal antibodies (mAbs) has bee...
<div><p>In recent years, high throughput discovery of human recombinant monoclonal antibodies (mAbs)...
In recent years, high throughput discovery of human recombinant monoclonal antibodies (mAbs) has bee...
We used the microarray technology to develop chips containing a comprehensive set of proteins and pe...
AbstractAn effective vaccine against human immunodeficiency virus type 1 (HIV-1) will have to provid...
<p>HIV-1 specific antibodies were tested against a panel of recombinant multi-clade gp140 and gp120 ...
The isolation of human monoclonal antibodies (mAbs) that neutralize a broad spectrum of primary HIV-...
The isolation of human monoclonal antibodies (mAbs) that neutralize a broad spectrum of primary HIV-...
Monoclonal antibodies to human immunodeficiency virus type 1 envelope glycoprotein gp 120 (HIV-1 gp1...
The identification and characterization of new human monoclonal antibodies (hMAbs) able to neutraliz...
Identification of broadly cross-reactive HIV-1-neutralizing antibodies (bnAbs) may assist vaccine im...
We have analyzed a panel of eight murine monoclonal antibodies (MAbs) that depend on the V2 domain f...
Identification of broadly cross-reactive HIV-1-neutralizing antibodies (bnAbs) may assist vaccine im...
The monitoring and assessment of a broadly neutralizing antibody (bnAb) based HIV-1 vaccine require ...
Several new human monoclonal antibodies (mAbs) with a neutralizing potential across different subtyp...
In recent years, high throughput discovery of human recombinant monoclonal antibodies (mAbs) has bee...
<div><p>In recent years, high throughput discovery of human recombinant monoclonal antibodies (mAbs)...
In recent years, high throughput discovery of human recombinant monoclonal antibodies (mAbs) has bee...
We used the microarray technology to develop chips containing a comprehensive set of proteins and pe...
AbstractAn effective vaccine against human immunodeficiency virus type 1 (HIV-1) will have to provid...
<p>HIV-1 specific antibodies were tested against a panel of recombinant multi-clade gp140 and gp120 ...
The isolation of human monoclonal antibodies (mAbs) that neutralize a broad spectrum of primary HIV-...
The isolation of human monoclonal antibodies (mAbs) that neutralize a broad spectrum of primary HIV-...
Monoclonal antibodies to human immunodeficiency virus type 1 envelope glycoprotein gp 120 (HIV-1 gp1...
The identification and characterization of new human monoclonal antibodies (hMAbs) able to neutraliz...
Identification of broadly cross-reactive HIV-1-neutralizing antibodies (bnAbs) may assist vaccine im...
We have analyzed a panel of eight murine monoclonal antibodies (MAbs) that depend on the V2 domain f...
Identification of broadly cross-reactive HIV-1-neutralizing antibodies (bnAbs) may assist vaccine im...
The monitoring and assessment of a broadly neutralizing antibody (bnAb) based HIV-1 vaccine require ...
Several new human monoclonal antibodies (mAbs) with a neutralizing potential across different subtyp...